“…Various approaches have been proposed to perform simultaneous detection of multiple tumor markers in the past few years. For example, electrochemical immunoassay (Wilson, 2007;Xu et al, 2014), label-free methods (Lin et al, 2011;Kong et al, 2013), dielectrophoresi assays (Lee et al, 2010;Ramón-Azcón et al, 2011), chemiluminescence alalysis (Zong et al, 2012;Guo et al, 2013), biobarcoded Scanometric assay (Stoeva et al, 2006), spectrometry (Chon et al, 2011;Giesen et al, 2011), fluorescence detection (Tian et al, 2012;Akinfieva et al, 2013), photonic suspension array (Zhao et al, 2009). But all these techniques are not suitable for point-of-care testing because they require large and sophisticated instruments, complex operations, long analysis time and highly skilled personnel to manipulate.…”